Caregivers of individuals diagnosed with acute leukemia face a difficult balancing act: meeting the urgent demands of cancer ...

A research team at Oregon Health & Science University has discovered a promising new drug combination that may help people with acute myeloid leukemia overcome resistance to one of the most common ...

OHSU researchers found that combining venetoclax with breast cancer drug palbociclib strongly improves AML treatment by ...

A research team at Oregon Health & Science University has discovered a promising new drug combination that may help people with acute myeloid leukemia ...

A research team at Oregon Health & Science University (OHSU) has discovered a promising new drug combination that may help people with acute myeloid leukaemia overcome resistance to one of the most ...

The findings, published in the New England Journal of Medicine by Robert Chiesa of Great Ormond Street Hospital for Children ...

Research on mRNA vaccines have been under fire in the post-pandemic age, but these immunotherapies are showing promise in the ...

A research team at Oregon Health & Science University has discovered a promising new drug combination that may help people ...

The Voice features host Gloria Burns in a meaningful conversation with Roxie Soto from the Leukemia & Lymphoma Society (LLS) to highlight the organization’s mission, patient support programs, ...

Amgen acquires Dark Blue Therapeutics for up to $840 million, adding early-stage leukemia drug research and strengthening its oncology discovery pipeline.

New research provides a mechanistic map of how genetic mutations disrupt RNA splicing in acute myeloid leukemia.

Researchers at Kumamoto University have uncovered a previously unknown molecular mechanism by which human T-cell leukemia ...